- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07705087
Impact of Plyometric Training Methods on Athletic Performance and Detraining Processes in Youth Female Soccer Players
10. Juli 2026 aktualisiert von: Fatih GUR, Pamukkale University
Lower extremity strength, explosive power, dynamic balance, and functional range of motion are critical determinants of athletic performance and injury prevention in soccer (football).
While plyometric training is widely used to improve these qualities, the comparative effects of bodyweight plyometric training versus externally loaded plyometric training, and the maintenance of these effects during detraining periods, remain unclear.
This study aims to investigate the effects of two different plyometric training methods on athletic performance and subsequent detraining processes in young female soccer players.
Participants will be randomly assigned to three groups: Bodyweight Plyometric Training Group (BW-PT), External Loading Plyometric Training Group (EL-PT, who will wear vests weighing 10% of their body weight), and Control Group (CG, who will only continue with routine soccer training).
Training interventions will be conducted for 6 weeks, immediately followed by a 4-week detraining period.
To comprehensively assess athletic performance, the following measurements will be taken at baseline (pre-test), immediately after the training period (post-test), and after the detraining period (maintenance test): Isokinetic muscle strength of knee extensors and flexors (peak torque and force development rate at 60°/s and 120°/s), Jumping performance (standing long jump, vertical jump height, and 15-second repeated jump test), Functional range of motion (via Functional Movement Screen - FMS), Dynamic balance (via Y-Balance Test).
The primary objective is to determine which plyometric loading strategy, compared to traditional soccer training, provides superior and longer-lasting physiological and biomechanical adaptations in young female athletes.
Studienübersicht
Status
Noch keine Rekrutierung
Bedingungen
Intervention / Behandlung
Studientyp
Interventionell
Einschreibung (Geschätzt)
36
Phase
- Unzutreffend
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienkontakt
- Name: Fatih GUR, PhD
- Telefonnummer: +90 258 236 14 88
- E-Mail: fatihgur@pau.edu.tr
Studienorte
-
-
Denizli
-
Denizli, Denizli, Türkei (türkiye), 20160
- Pamukkale University, Faculty of Sport Sciences
-
Kontakt:
- Fatih GUR, PhD
- Telefonnummer: +90 258 296 14 88
- E-Mail: fatihgur@pau.edu.tr
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
- Kind
- Erwachsene
Akzeptiert gesunde Freiwillige
Ja
Beschreibung
Inclusion Criteria:
- No history of surgery due to musculoskeletal injuries within the past 6 months.
- No use of ergogenic supplements within the past 3 months.
- Regular participation in routine team training sessions for at least 2 months prior to the study.
Exclusion Criteria:
- History of any recent injury requiring a recovery period of more than one week.
- Use of ergogenic aids or nutritional supplements during the intervention period.
- Missing two consecutive or four non-consecutive training sessions during the study period.
- Participation in additional structured physical training or exercises outside of the routine team practices and the study protocol.
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Grundlegende Wissenschaft
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Body-Weight Plyometric Training Group
Participants in this group will perform plyometric training using only their own body weight.
|
A structured plyometric training program performed twice a week for six weeks.
Exercises include various jumps and bounds using only the participant's body weight.
Each session lasts approximately 30 minutes.
|
|
Experimental: Plyometric Training Group With Additional Load
Participants in this group will perform plyometric training while wearing a weighted vest equal to 10% of their body weight.
|
A structured plyometric training program performed twice a week for six weeks.
Participants will wear a weighted vest equivalent to 10% of their body weight during the exercises.
Each session lasts approximately 30 minutes.
|
|
Aktiver Komparator: Control Group
Participants in this group will continue their routine football training without any additional plyometric exercises.
|
Participants in this group will continue to perform their standard, routine football training sessions.
They will not receive any additional or structured plyometric training program during the intervention period.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Absolute Peak Torque (APT) of Knee Extensors and Flexors
Zeitfenster: Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
Concentric isokinetic absolute peak torque (APT) of the knee extensors and flexors (dominant leg) will be evaluated at 60°/s and 120°/s angular velocities using a Cybex Humac Norm dynamometer during 5 maximal repetitions.
(Unit of measure: Nm)
|
Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
|
Relative Peak Torque (RPT) of Knee Extensors and Flexors
Zeitfenster: Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
Concentric isokinetic relative peak torque (RPT) of the knee extensors and flexors (dominant leg) will be evaluated at 60°/s and 120°/s angular velocities using a Cybex Humac Norm dynamometer during 5 maximal repetitions.
(Unit of measure: Nm/kg)
|
Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
|
Time to Peak Torque (TPT) of Knee Extensors and Flexors
Zeitfenster: Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
Concentric isokinetic time to peak torque (TPT) of the knee extensors and flexors (dominant leg) will be evaluated at 60°/s and 120°/s angular velocities using a Cybex Humac Norm dynamometer during 5 maximal repetitions.
(Unit of measure: milliseconds)
|
Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
|
Average Peak Torque (AvPT) of Knee Extensors and Flexors
Zeitfenster: Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
Concentric isokinetic average peak torque (AvPT) of the knee extensors and flexors (dominant leg) will be evaluated at 60°/s and 120°/s angular velocities using a Cybex Humac Norm dynamometer during 5 maximal repetitions.
(Unit of measure: Nm)
|
Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
|
Average Rate of Force Development (AvRFD) of Knee Extensors and Flexors
Zeitfenster: Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
Concentric isokinetic average rate of force development (AvRFD) of the knee extensors and flexors (dominant leg) will be evaluated at 60°/s and 120°/s angular velocities using a Cybex Humac Norm dynamometer during 5 maximal repetitions.
(Unit of measure: Nm/s)
|
Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
|
Vertical Jump Height (VJH)
Zeitfenster: Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
Vertical jump height calculated from flight time will be evaluated using an electronic contact mat system (Fusion SmartJump, Fusion Sport, Australia).
Participants will perform a countermovement jump without arm swing.
The best value from 3 repetitions, separated by 1-minute rest intervals, will be recorded.
(Unit of measure: cm)
|
Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
|
Standing Long Jump (SLJ) Distance
Zeitfenster: Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
Horizontal jump distance will be assessed.
Participants will perform a maximum distance jump with two feet from behind a starting line.
The best value from 3 repetitions will be recorded.
(Unit of measure: cm)
|
Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
|
15-Second Repeated Jump Test: Average Power (RJ15s-AP)
Zeitfenster: Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
Average power (RJ15s-AP) will be evaluated during 15 seconds of continuous maximal vertical jumps using an electronic contact mat system (Fusion SmartJump, Fusion Sport, Australia).
Participants will jump with hands on hips and an upright trunk.
The value is calculated using the Bosco equation.
(Unit of Measure: W)
|
Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
|
15-Second Repeated Jump Test: Flight Time (RJ15s-FT)
Zeitfenster: Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
Flight time (RJ15s-FT) will be evaluated during 15 seconds of continuous maximal vertical jumps using an electronic contact mat system (Fusion SmartJump, Fusion Sport, Australia).
Participants will jump with hands on hips and an upright trunk.
The value is calculated using the Bosco equation.
(Unit of Measure: ms)
|
Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
|
15-Second Repeated Jump Test: Number of Jumps (N-RJ15s)
Zeitfenster: Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
The number of jumps (N-RJ15s) will be evaluated during 15 seconds of continuous maximal vertical jumps using an electronic contact mat system (Fusion SmartJump, Fusion Sport, Australia).
Participants will jump with hands on hips and an upright trunk.
(Unit of Measure: Count)
|
Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Functional Movement Capacity
Zeitfenster: Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
Functional movement capacity and potential asymmetries will be evaluated using the Functional Movement Screen (FMS) kit, which consists of 7 movement patterns scored from 0 to 3 (max total score: 21).
(Unit of measure: Score on a scale from 0 to 21)
|
Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
|
Dynamic Balance and Neuromuscular Control
Zeitfenster: Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
Dynamic balance will be measured using the Y-Balance Test kit.
Reach distances in three directions will be normalized to the participant's leg length to assess lower extremity neuromuscular control and asymmetry.
(Unit of measure: Percentage)
|
Baseline (Week 0), immediately post-training (Week 6), and after the detraining period (2nd and 4th week).
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Sponsor
Ermittler
- Hauptermittler: GUR, Pamukkale University
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Geschätzt)
20. Juli 2026
Primärer Abschluss (Geschätzt)
19. Oktober 2026
Studienabschluss (Geschätzt)
19. Oktober 2026
Studienanmeldedaten
Zuerst eingereicht
2. Juli 2026
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
10. Juli 2026
Zuerst gepostet (Tatsächlich)
15. Juli 2026
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
15. Juli 2026
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
10. Juli 2026
Zuletzt verifiziert
1. Juli 2026
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
- E-60116787-020-811428
- 2026TAP009 (Andere Zuschuss-/Finanzierungsnummer: Pamukkale University Scientific Research Projects Coordination Unit)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
NEIN
Beschreibung des IPD-Plans
Individual participant data (IPD) will not be shared.
The informed consent obtained from the participants does not include provisions for public data sharing.
Furthermore, preserving the privacy and complete anonymization of the participants in this small, cohort-specific sports science study is a priority, which restricts the feasibility of sharing individual-level data.
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Nein
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Nein
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .